Dr.Zone AI

Cardiology | Medical Specialty / Cardiology | Dr.Zone AI

Cardiology (Medical Specialty / Cardiology): 🚨 Breaking News in Lipid Management The FDA has approved LIPFENDRA® (enlicitide) 20 mg, the first once-daily oral PCSK9 inhibitor, as an adjunct to diet and exercise for reducing...